Ribar Brandon (President & CEO) reported special transactions (Non-P/S).
Ribar Brandon (President & CEO) reported special transactions (Non-P/S).
Cober Timothy (SVP & Chief Accounting Officer) reported special transactions (Non-P/S).
Cober Timothy (SVP & Chief Accounting Officer) reported special transactions (Non-P/S).
Read more: www.onclive.com/view/fda-acc...
Read more: www.onclive.com/view/fda-acc...
FDA Approves sNDA Adding MAPLE-HCM Data to MYQORZO Label
FDA approved the sNDA updating the U.S. Prescribing Information for MYQORZO (aficamten) to include Phase 3 MAPLE-HCM data comparing aficamten with metoprolol. Approval came …
https://biostock.app/symbols/CYTK
FDA Approves sNDA Adding MAPLE-HCM Data to MYQORZO Label
FDA approved the sNDA updating the U.S. Prescribing Information for MYQORZO (aficamten) to include Phase 3 MAPLE-HCM data comparing aficamten with metoprolol. Approval came …
https://biostock.app/symbols/CYTK
Full hub: https://www.merlintrader.com/karyopharm-therapeutics-stock-hub/?utm_source=bluesky&utm_medium=social&utm_campaign=kpti
Full hub: https://www.merlintrader.com/karyopharm-therapeutics-stock-hub/?utm_source=bluesky&utm_medium=social&utm_campaign=kpti
FDA STAR Pilot Program Entry - plozasiran sNDA in sHTG (6-month Priority Review)
FDA granted plozasiran entry in the Split Real Time Application Review (STAR) pilot program for the sHTG sNDA. Acceptance qualifies for a 6-month …
https://biostock.app/symbols/ARWR
FDA STAR Pilot Program Entry - plozasiran sNDA in sHTG (6-month Priority Review)
FDA granted plozasiran entry in the Split Real Time Application Review (STAR) pilot program for the sHTG sNDA. Acceptance qualifies for a 6-month …
https://biostock.app/symbols/ARWR
Dark pool volume Nov 11: 0.5x its normal level, 5-day trend rising.
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Full story at the link.
#darkpool #stocks #stockmarket
Dark pool volume Nov 11: 0.5x its normal level, 5-day trend rising.
Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days.
Full story at the link.
#darkpool #stocks #stockmarket
https://fundspec.ai/s/SNDA/analysts
Compare any stock to its DCF fair value in seconds.
https://fundspec.ai/s/SNDA/analysts
Compare any stock to its DCF fair value in seconds.
https://www.byteseu.com/2516762/
Daiichi Sankyo has submitted a supplemental New Drug Application (sNDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) for trastuzumab deruxtecan …
https://www.byteseu.com/2516762/
Daiichi Sankyo has submitted a supplemental New Drug Application (sNDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) for trastuzumab deruxtecan …
FDA Approves RYZUMVI (Phentolamine 0.75%) for Presbyopia - Milestone Payment from Viatris
Q3 2026 results 8-K reports FDA approval of the sNDA for phentolamine ophthalmic solution 0.75% (RYZUMVI) for presbyopia in adults, the second…
https://biostock.app/symbols/IRD
FDA Approves RYZUMVI (Phentolamine 0.75%) for Presbyopia - Milestone Payment from Viatris
Q3 2026 results 8-K reports FDA approval of the sNDA for phentolamine ophthalmic solution 0.75% (RYZUMVI) for presbyopia in adults, the second…
https://biostock.app/symbols/IRD
🔗 www.onclive.com/view/gedatol...
#bcsm #oncology
🔗 www.onclive.com/view/gedatol...
#bcsm #oncology
#stocks #investing #earnings
#stocks #investing #earnings
Sonida Senior Living held an earnings call to discuss results from its third quarter.
via Yahoo Finance
seniorliving.news/story/what-s...
Sonida Senior Living held an earnings call to discuss results from its third quarter.
via Yahoo Finance
seniorliving.news/story/what-s...
https://www.stocktitan.net/news/CELC/celcuity-announces-fda-acceptance-of-s-nda-for-revtorpyktm-aqro7lxzfbcd.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/CELC/celcuity-announces-fda-acceptance-of-s-nda-for-revtorpyktm-aqro7lxzfbcd.html?utm_source=stocktitan-bluesky&utm_medium=social
Attached hereto as Exhibit 99.2 is the investor presentation used in connection with the Company’s webcast.
Attached hereto as Exhibit 99.2 is the investor presentation used in connection with the Company’s webcast.
https://fundspec.ai/s/SNDA/earnings
50+ fundamentals like ROIC and free cash flow yield, ranked against the whole market.
https://fundspec.ai/s/SNDA/earnings
50+ fundamentals like ROIC and free cash flow yield, ranked against the whole market.
https://www.stocktitan.net/news/SNDA/sonida-senior-living-announces-third-quarter-2026-5gv7k6jqgadv.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/SNDA/sonida-senior-living-announces-third-quarter-2026-5gv7k6jqgadv.html?utm_source=stocktitan-bluesky&utm_medium=social
📈 Zevra anticipates filing MIPLYFFA sNDA in Q1 2027.
⚖️ Indonesia regulator announces stock violations sanctions.
📈 Zevra anticipates filing MIPLYFFA sNDA in Q1 2027.
⚖️ Indonesia regulator announces stock violations sanctions.
Full details ➡️: www.onclive.com/view/fda-gra...
#oncology #lymsm
Full details ➡️: www.onclive.com/view/fda-gra...
#oncology #lymsm